The Heart Failure Industry Has It Wrong, This Tiny Turbine Could Fix It with Arnaud Mascarell

The Heart Failure Industry Has It Wrong, This Tiny Turbine Could Fix It with Arnaud Mascarell

May 15, 2026 · 46 min

About this episode

Arnaud Mascarell discusses the innovative FlowMaker device and the challenges in the heart failure industry.

In this episode of Crux of Cardio, Jordan Burgin sits down with Arnaud Mascarell, CEO and Co-Founder of FineHeart, the Bordeaux-based company behind the FlowMaker, a fully implantable cardiac assist device that works in synchrony with the heart's natural contraction rather than replacing it.Arnaud shares the full journey: 18 years at Medtronic pioneering CRT pacemakers, the origin story that started with a child's toy boat, why the current approach to heart failure is fundamentally broken, and what it takes to spend a decade building a device that nobody else has been able to replicate. He also opens up on fundraising in European medtech, securing a €48M EU grant, and why he measures success in patients saved rather than acquisition price. Key Topics: Why the heart failure industry is failing patients between medication and late-stage devices The FlowMaker: a fully implantable, wireless, synchronized cardiac assist deviceThe origin story behind FineHeart and the CRT pacemaker connection Eliminating the driveline and what that means for patient quality of life Wireless energy transfer as a platform technology for all active implantables Fundraising a €100M+ medtech startup with…

People in this episode

Host: Jordan Burgin

Guest: Arnaud Mascarell

Topics covered

Keywords

Mentioned in this episode

Organizations: FineHeart, Medtronic

Products: FlowMaker

Places: Bordeaux

More episodes of The Crux of Medtech

Explore listener stats, chart rankings, contacts and more on the The Crux of Medtech podcast page.